Navigation Links
BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
Date:9/19/2007

BIRMINGHAM, Ala., Sept. 19 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced preliminary findings from a Phase II study with intramuscular (i.m.) injection of peramivir, the Company's product candidate for the treatment of seasonal and life-threatening influenza.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030414/BIOCRYSTLOGO )

The study was a randomized, double-blind, placebo-controlled clinical trial designed to test whether peramivir, when administered acutely in high doses intramuscularly, could reduce the duration of symptoms during seasonal influenza. 344 patients who had a positive rapid antigen test indicating acute influenza illness were randomized to receive intramuscular injections of either placebo or one of two dose levels of peramivir (150mg and 300mg) as a single dose administered within 48 hours of symptom onset. The primary endpoint of the study was the time to alleviation of symptoms in the patients with confirmed influenza infection (n=313).

While the results indicate that in the evaluable population of 313 subjects, a single dose of peramivir demonstrated a treatment improvement over placebo, the improvement was not statistically significant. With regard to the primary endpoint of median time to alleviation of symptoms, the improvement over placebo was 22.9 hours with the 150mg dose (p=0.284) and 21.1 hours with the 300mg dose (p=0.152). Based on a preliminary review, the Company believes that due to the introduction of a shorter injection needle in the Phase II trial compared to the Phase I trial, only one-third of subjects received an adequate intramuscula
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... Oct. 26, 2011 The following is a letter ... Ltd. (OTCBB: HADSY), a publicly traded portfolio of biotech ... Hadassah University Hospital. Dear Fellow Investors, ... establishment by the Hadassah University Hospital and its IPO ...
... this smorgasbord of recent salmonella outbreaks in the United ... 2011 alone, and the list goes on, according to ... perhaps not for long, thanks to a promising new ... bacteria before contaminated food or animals reach the marketplace. ...
... and IPSWICH, Mass., Oct. 25, 2011 SwitchGear ... services for studying regulatory elements in the human genome, ... Inc. (NEB) to create a new dual reporter assay ... Luciferase Assay System and NEB,s BioLux® Cypridina ...
Cached Biology Technology:Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 2Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 3Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 4Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 5Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders 6SwitchGear Genomics and New England Biolabs Develop New Multiplex Reporter Assay System 2
(Date:4/15/2014)... 2020 how high sea levels will rise into the ... Florida International University scientist Rene Price. , Price is ... Coastal Everglades Long-Term Ecological Research (LTER) site, one of ... reefs to deserts, mountains to salt marshes around the ... one of the most certain consequences of climate change. ...
(Date:4/15/2014)... If an insect drew a line as it ... a tangled mess. But there,s method to that mess, ... engineering and physics, who tries to find simple physical ... https://cornell.box.com/tbeetle , It turns out the tiger beetle, ... reorientation dance as it chases its prey at blinding ...
(Date:4/15/2014)... 15, 2014) The American Association of Anatomists (AAA) ... All awards will be presented during the Closing Awards ... on Tuesday, April 29th at 7:30 p.m. during AAA,s ... The 2014 award winners are: , ... of the Icahn School of Medicine at Mount Sinai, ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2Photo: Tiger beetle's chase highlights mechanical law 2American Association of Anatomists 2014 award winners 2
... 2008. A research project supported by the BBVA Foundation ... of Applied Bioacoustics at the UPC (Universitat Politcnica de ... measuring cetacean hearing sensitivity. , This audiogram measurement ... allowing assessments to be run on the survival chances ...
... December 15 WCC Services, the,leading provider of ... 6 of its flagship product, ELISE, is now ... hundreds of applicants for,each job opening making it ... job.,Security concerns are also at peak levels, requiring ...
... The American Society for Microbiology (ASM) has been honored ... two of its public outreach initiatives. The awards ... The Society,s MicrobeWorld Video series received the award ... online video series strives to increase public understanding and ...
Cached Biology News:A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss 2A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss 3WCC Announces Version 6 of its ELISE Smart Search and Match Platform for Employment and Biometric Matching 2
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
... Mouse monoclonal [SPM278] to 67kD Laminin ... lung carcinoma N592 live cells (Human). ... Not yet tested in other species. ... major glycoproteins of basement membrane, displays multiple ...
Hybridization Buffer 3.6 ml...
...
Biology Products: